Global and China Parkinson's Disease (PD) Drugs Market Insights, Forecast to 2027

Publisher Name :
Date: 12-Oct-2021
No. of pages: 152
Inquire Before Buying

Parkinson's Disease (PD) Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Parkinson's Disease (PD) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For China market, this report focuses on the Parkinson's Disease (PD) Drugs market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type

- Dopamine Agonist

- Monoamine Oxidase Inhibitors

- Acetylcholinesterase Inhibitors

- Glutamate Inhibitors

Segment by Application

- Hospital

- Family

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- Boehringer Ingelheim

- GlaxoSmithKline

- Novartis

- Teva Pharmaceutical Industries

- AbbVie

- Abital Pharma

- Addex Therapeutics

- Biogen

- Eisai

- Eli Lilly

- F. Hoffmann-La Roche

- H. Lundbeck

- Impax Laboratories

- Kyowa Hakko Kirin

- Otsuka Pharmaceutical

- Pfizer

Global and China Parkinson's Disease (PD) Drugs Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Parkinson's Disease (PD) Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Parkinson's Disease (PD) Drugs Market Size Growth Rate by Type
1.2.2 Dopamine Agonist
1.2.3 Monoamine Oxidase Inhibitors
1.2.4 Acetylcholinesterase Inhibitors
1.2.5 Glutamate Inhibitors
1.3 Market by Application
1.3.1 Global Parkinson's Disease (PD) Drugs Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 Family
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Parkinson's Disease (PD) Drugs Market Size, Estimates and Forecasts
2.1.1 Global Parkinson's Disease (PD) Drugs Revenue 2016-2027
2.1.2 Global Parkinson's Disease (PD) Drugs Sales 2016-2027
2.2 Global Parkinson's Disease (PD) Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Parkinson's Disease (PD) Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global Parkinson's Disease (PD) Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Parkinson's Disease (PD) Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Parkinson's Disease (PD) Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Parkinson's Disease (PD) Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global Parkinson's Disease (PD) Drugs Revenue Forecast by Region (2022-2027)
3 Global Parkinson's Disease (PD) Drugs Competitor Landscape by Players
3.1 Global Top Parkinson's Disease (PD) Drugs Manufacturers by Sales
3.1.1 Global Parkinson's Disease (PD) Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global Parkinson's Disease (PD) Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Parkinson's Disease (PD) Drugs Manufacturers by Revenue
3.2.1 Key Parkinson's Disease (PD) Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global Parkinson's Disease (PD) Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global Parkinson's Disease (PD) Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Parkinson's Disease (PD) Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Parkinson's Disease (PD) Drugs Revenue in 2020
3.2.6 Global Parkinson's Disease (PD) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Parkinson's Disease (PD) Drugs Price by Manufacturers
3.4 Global Parkinson's Disease (PD) Drugs Manufacturing Base Distribution, Product Types
3.4.1 Parkinson's Disease (PD) Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Parkinson's Disease (PD) Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Parkinson's Disease (PD) Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Parkinson's Disease (PD) Drugs Market Size by Type (2016-2021)
4.1.1 Global Parkinson's Disease (PD) Drugs Sales by Type (2016-2021)
4.1.2 Global Parkinson's Disease (PD) Drugs Revenue by Type (2016-2021)
4.1.3 Parkinson's Disease (PD) Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Parkinson's Disease (PD) Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global Parkinson's Disease (PD) Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Parkinson's Disease (PD) Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Parkinson's Disease (PD) Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Parkinson's Disease (PD) Drugs Market Size by Application (2016-2021)
5.1.1 Global Parkinson's Disease (PD) Drugs Sales by Application (2016-2021)
5.1.2 Global Parkinson's Disease (PD) Drugs Revenue by Application (2016-2021)
5.1.3 Parkinson's Disease (PD) Drugs Price by Application (2016-2021)
5.2 Parkinson's Disease (PD) Drugs Market Size Forecast by Application (2022-2027)
5.2.1 Global Parkinson's Disease (PD) Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Parkinson's Disease (PD) Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Parkinson's Disease (PD) Drugs Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Parkinson's Disease (PD) Drugs Market Size YoY Growth 2016-2027
6.1.1 China Parkinson's Disease (PD) Drugs Sales YoY Growth 2016-2027
6.1.2 China Parkinson's Disease (PD) Drugs Revenue YoY Growth 2016-2027
6.1.3 China Parkinson's Disease (PD) Drugs Market Share in Global Market 2016-2027
6.2 China Parkinson's Disease (PD) Drugs Market Size by Players (International and Local Players)
6.2.1 China Top Parkinson's Disease (PD) Drugs Players by Sales (2016-2021)
6.2.2 China Top Parkinson's Disease (PD) Drugs Players by Revenue (2016-2021)
6.3 China Parkinson's Disease (PD) Drugs Historic Market Review by Type (2016-2021)
6.3.1 China Parkinson's Disease (PD) Drugs Sales Market Share by Type (2016-2021)
6.3.2 China Parkinson's Disease (PD) Drugs Revenue Market Share by Type (2016-2021)
6.3.3 China Parkinson's Disease (PD) Drugs Price by Type (2016-2021)
6.4 China Parkinson's Disease (PD) Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Parkinson's Disease (PD) Drugs Sales Forecast by Type (2022-2027)
6.4.2 China Parkinson's Disease (PD) Drugs Revenue Forecast by Type (2022-2027)
6.4.3 China Parkinson's Disease (PD) Drugs Price Forecast by Type (2022-2027)
6.5 China Parkinson's Disease (PD) Drugs Historic Market Review by Application (2016-2021)
6.5.1 China Parkinson's Disease (PD) Drugs Sales Market Share by Application (2016-2021)
6.5.2 China Parkinson's Disease (PD) Drugs Revenue Market Share by Application (2016-2021)
6.5.3 China Parkinson's Disease (PD) Drugs Price by Application (2016-2021)
6.6 China Parkinson's Disease (PD) Drugs Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Parkinson's Disease (PD) Drugs Sales Forecast by Application (2022-2027)
6.6.2 China Parkinson's Disease (PD) Drugs Revenue Forecast by Application (2022-2027)
6.6.3 China Parkinson's Disease (PD) Drugs Price Forecast by Application (2022-2027)
7 North America
7.1 North America Parkinson's Disease (PD) Drugs Market Size YoY Growth 2016-2027
7.2 North America Parkinson's Disease (PD) Drugs Market Facts & Figures by Country
7.2.1 North America Parkinson's Disease (PD) Drugs Sales by Country (2016-2021)
7.2.2 North America Parkinson's Disease (PD) Drugs Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Parkinson's Disease (PD) Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific Parkinson's Disease (PD) Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific Parkinson's Disease (PD) Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific Parkinson's Disease (PD) Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Parkinson's Disease (PD) Drugs Market Size YoY Growth 2016-2027
9.2 Europe Parkinson's Disease (PD) Drugs Market Facts & Figures by Country
9.2.1 Europe Parkinson's Disease (PD) Drugs Sales by Country (2016-2021)
9.2.2 Europe Parkinson's Disease (PD) Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Parkinson's Disease (PD) Drugs Market Size YoY Growth 2016-2027
10.2 Latin America Parkinson's Disease (PD) Drugs Market Facts & Figures by Country
10.2.1 Latin America Parkinson's Disease (PD) Drugs Sales by Country (2016-2021)
10.2.2 Latin America Parkinson's Disease (PD) Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Parkinson's Disease (PD) Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Parkinson's Disease (PD) Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa Parkinson's Disease (PD) Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Boehringer Ingelheim
12.1.1 Boehringer Ingelheim Corporation Information
12.1.2 Boehringer Ingelheim Description and Business Overview
12.1.3 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Products Offered
12.1.5 Boehringer Ingelheim Recent Development
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Corporation Information
12.2.2 GlaxoSmithKline Description and Business Overview
12.2.3 GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 GlaxoSmithKline Parkinson's Disease (PD) Drugs Products Offered
12.2.5 GlaxoSmithKline Recent Development
12.3 Novartis
12.3.1 Novartis Corporation Information
12.3.2 Novartis Description and Business Overview
12.3.3 Novartis Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Novartis Parkinson's Disease (PD) Drugs Products Offered
12.3.5 Novartis Recent Development
12.4 Teva Pharmaceutical Industries
12.4.1 Teva Pharmaceutical Industries Corporation Information
12.4.2 Teva Pharmaceutical Industries Description and Business Overview
12.4.3 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Products Offered
12.4.5 Teva Pharmaceutical Industries Recent Development
12.5 AbbVie
12.5.1 AbbVie Corporation Information
12.5.2 AbbVie Description and Business Overview
12.5.3 AbbVie Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 AbbVie Parkinson's Disease (PD) Drugs Products Offered
12.5.5 AbbVie Recent Development
12.6 Abital Pharma
12.6.1 Abital Pharma Corporation Information
12.6.2 Abital Pharma Description and Business Overview
12.6.3 Abital Pharma Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Abital Pharma Parkinson's Disease (PD) Drugs Products Offered
12.6.5 Abital Pharma Recent Development
12.7 Addex Therapeutics
12.7.1 Addex Therapeutics Corporation Information
12.7.2 Addex Therapeutics Description and Business Overview
12.7.3 Addex Therapeutics Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Addex Therapeutics Parkinson's Disease (PD) Drugs Products Offered
12.7.5 Addex Therapeutics Recent Development
12.8 Biogen
12.8.1 Biogen Corporation Information
12.8.2 Biogen Description and Business Overview
12.8.3 Biogen Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Biogen Parkinson's Disease (PD) Drugs Products Offered
12.8.5 Biogen Recent Development
12.9 Eisai
12.9.1 Eisai Corporation Information
12.9.2 Eisai Description and Business Overview
12.9.3 Eisai Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Eisai Parkinson's Disease (PD) Drugs Products Offered
12.9.5 Eisai Recent Development
12.10 Eli Lilly
12.10.1 Eli Lilly Corporation Information
12.10.2 Eli Lilly Description and Business Overview
12.10.3 Eli Lilly Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Eli Lilly Parkinson's Disease (PD) Drugs Products Offered
12.10.5 Eli Lilly Recent Development
12.11 Boehringer Ingelheim
12.11.1 Boehringer Ingelheim Corporation Information
12.11.2 Boehringer Ingelheim Description and Business Overview
12.11.3 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Products Offered
12.11.5 Boehringer Ingelheim Recent Development
12.12 H. Lundbeck
12.12.1 H. Lundbeck Corporation Information
12.12.2 H. Lundbeck Description and Business Overview
12.12.3 H. Lundbeck Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.12.4 H. Lundbeck Products Offered
12.12.5 H. Lundbeck Recent Development
12.13 Impax Laboratories
12.13.1 Impax Laboratories Corporation Information
12.13.2 Impax Laboratories Description and Business Overview
12.13.3 Impax Laboratories Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Impax Laboratories Products Offered
12.13.5 Impax Laboratories Recent Development
12.14 Kyowa Hakko Kirin
12.14.1 Kyowa Hakko Kirin Corporation Information
12.14.2 Kyowa Hakko Kirin Description and Business Overview
12.14.3 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Kyowa Hakko Kirin Products Offered
12.14.5 Kyowa Hakko Kirin Recent Development
12.15 Otsuka Pharmaceutical
12.15.1 Otsuka Pharmaceutical Corporation Information
12.15.2 Otsuka Pharmaceutical Description and Business Overview
12.15.3 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Otsuka Pharmaceutical Products Offered
12.15.5 Otsuka Pharmaceutical Recent Development
12.16 Pfizer
12.16.1 Pfizer Corporation Information
12.16.2 Pfizer Description and Business Overview
12.16.3 Pfizer Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Pfizer Products Offered
12.16.5 Pfizer Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Parkinson's Disease (PD) Drugs Industry Trends
13.2 Parkinson's Disease (PD) Drugs Market Drivers
13.3 Parkinson's Disease (PD) Drugs Market Challenges
13.4 Parkinson's Disease (PD) Drugs Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Parkinson's Disease (PD) Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Parkinson's Disease (PD) Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Dopamine Agonist
Table 3. Major Manufacturers of Monoamine Oxidase Inhibitors
Table 4. Major Manufacturers of Acetylcholinesterase Inhibitors
Table 5. Major Manufacturers of Glutamate Inhibitors
Table 6. Global Parkinson's Disease (PD) Drugs Market Size Growth Rate by Application (2021-2027) & (K Pcs)
Table 7. Global Parkinson's Disease (PD) Drugs Market Size by Region (K Pcs) & (US$ Million), 2016 VS 2021 VS 2027
Table 8. Global Parkinson's Disease (PD) Drugs Sales by Regions (2016-2021) & (K Pcs)
Table 9. Global Parkinson's Disease (PD) Drugs Sales Market Share by Regions (2016-2021)
Table 10. Global Parkinson's Disease (PD) Drugs Revenue by Regions (2016-2021) & (US$ Million)
Table 11. Global Parkinson's Disease (PD) Drugs Sales Forecast by Region (2022-2027) & (K Pcs)
Table 12. Global Parkinson's Disease (PD) Drugs Sales Market Share Forecast by Region (2022-2027)
Table 13. Global Parkinson's Disease (PD) Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 14. Global Parkinson's Disease (PD) Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 15. Global Parkinson's Disease (PD) Drugs Sales by Manufacturers (2016-2021) (K Pcs)
Table 16. Global Parkinson's Disease (PD) Drugs Sales Share by Manufacturers (2016-2021)
Table 17. Ranking of Global Top Parkinson's Disease (PD) Drugs Manufacturers by Revenue (US$ Million) in 2020
Table 18. Parkinson's Disease (PD) Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
Table 19. Parkinson's Disease (PD) Drugs Revenue Share by Manufacturers (2016-2021)
Table 20. Global Parkinson's Disease (PD) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 21. Global Parkinson's Disease (PD) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson's Disease (PD) Drugs as of 2020)
Table 22. Key Manufacturers Parkinson's Disease (PD) Drugs Price (2016-2021) (USD/Pcs)
Table 23. Parkinson's Disease (PD) Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Parkinson's Disease (PD) Drugs Product Type
Table 25. Date of International Manufacturers Enter into Parkinson's Disease (PD) Drugs Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Parkinson's Disease (PD) Drugs Sales by Type (2016-2021) (K Pcs)
Table 28. Global Parkinson's Disease (PD) Drugs Sales Share by Type (2016-2021)
Table 29. Global Parkinson's Disease (PD) Drugs Revenue by Type (2016-2021) (US$ Million)
Table 30. Global Parkinson's Disease (PD) Drugs Revenue Share by Type (2016-2021)
Table 31. Parkinson's Disease (PD) Drugs Average Selling Price (ASP) by Type (2016-2021) & (USD/Pcs)
Table 32. Global Parkinson's Disease (PD) Drugs Sales Forecast by Type (2022-2027) & (K Pcs)
Table 33. Global Parkinson's Disease (PD) Drugs Sales Market Share Forecast by Type (2022-2027)
Table 34. Global Parkinson's Disease (PD) Drugs Revenue Forecast V (2022-2027) & (US$ Million)
Table 35. Global Parkinson's Disease (PD) Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 36. Global Parkinson's Disease (PD) Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Pcs)
Table 37. Global Parkinson's Disease (PD) Drugs Sales by Application (2016-2021) (K Pcs)
Table 38. Global Parkinson's Disease (PD) Drugs Sales Share by Application (2016-2021)
Table 39. Global Parkinson's Disease (PD) Drugs Revenue by Application (2016-2021) (US$ Million)
Table 40. Global Parkinson's Disease (PD) Drugs Revenue Share by Application (2016-2021)
Table 41. Parkinson's Disease (PD) Drugs Average Selling Price (ASP) by Application (2016-2021) & (USD/Pcs)
Table 42. Global Parkinson's Disease (PD) Drugs Sales Forecast by Application (2022-2027) & (K Pcs)
Table 43. Global Parkinson's Disease (PD) Drugs Sales Market Share Forecast by Application (2022-2027)
Table 44. Global Parkinson's Disease (PD) Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 45. Global Parkinson's Disease (PD) Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 46. Global Parkinson's Disease (PD) Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Pcs)
Table 47. China Parkinson's Disease (PD) Drugs Sales (K Pcs) of Key Companies (2016-2021)
Table 48. China Parkinson's Disease (PD) Drugs Sales Share by Company (2016-2021)
Table 49. China Parkinson's Disease (PD) Drugs Revenue (US$ Million) by Company (2016-2021)
Table 50. China Parkinson's Disease (PD) Drugs Revenue Share by Company (2016-2021)
Table 51. China Parkinson's Disease (PD) Drugs Sales (K Pcs) by Type (2016-2021)
Table 52. China Parkinson's Disease (PD) Drugs Sales Share by Type (2016-2021)
Table 53. China Parkinson's Disease (PD) Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 54. China Parkinson's Disease (PD) Drugs Price (USD/Pcs) by Type (2016-2021)
Table 55. China Parkinson's Disease (PD) Drugs Sales (K Pcs) by Type (2022-2027)
Table 56. China Parkinson's Disease (PD) Drugs Sales Share by Type (2022-2027)
Table 57. China Parkinson's Disease (PD) Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 58. China Parkinson's Disease (PD) Drugs Revenue Share by Type (2022-2027)
Table 59. China Parkinson's Disease (PD) Drugs Price (USD/Pcs) by Type (2022-2027)
Table 60. China Parkinson's Disease (PD) Drugs Sales (K Pcs) by Application (2016-2021)
Table 61. China Parkinson's Disease (PD) Drugs Sales Share by Application (2016-2021)
Table 62. China Parkinson's Disease (PD) Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 63. China Parkinson's Disease (PD) Drugs Price (USD/Pcs) by Application (2016-2021)
Table 64. China Parkinson's Disease (PD) Drugs Sales (K Pcs) by Application (2022-2027)
Table 65. China Parkinson's Disease (PD) Drugs Sales Share by Application (2022-2027)
Table 66. China Parkinson's Disease (PD) Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 67. China Parkinson's Disease (PD) Drugs Revenue Share by Application (2022-2027)
Table 68. China Parkinson's Disease (PD) Drugs Price (USD/Pcs) by Application (2022-2027)
Table 69. North America Parkinson's Disease (PD) Drugs Sales by Country (2016-2021) & (K Pcs)
Table 70. North America Parkinson's Disease (PD) Drugs Sales Market Share by Country (2016-2021)
Table 71. North America Parkinson's Disease (PD) Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 72. North America Parkinson's Disease (PD) Drugs Revenue Market Share by Country (2016-2021)
Table 73. Asia Pacific Parkinson's Disease (PD) Drugs Sales by Region (2016-2021) & (K Pcs)
Table 74. Asia Pacific Parkinson's Disease (PD) Drugs Sales Market Share by Region (2016-2021)
Table 75. Asia Pacific Parkinson's Disease (PD) Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 76. Asia Pacific Parkinson's Disease (PD) Drugs Revenue Market Share by Region (2016-2021)
Table 77. Europe Parkinson's Disease (PD) Drugs Sales by Country (2016-2021) & (K Pcs)
Table 78. Europe Parkinson's Disease (PD) Drugs Sales Market Share by Country (2016-2021)
Table 79. Europe Parkinson's Disease (PD) Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 80. Europe Parkinson's Disease (PD) Drugs Revenue Market Share by Country (2016-2021)
Table 81. Latin America Parkinson's Disease (PD) Drugs Sales by Country (2016-2021) & (K Pcs)
Table 82. Latin America Parkinson's Disease (PD) Drugs Sales Market Share by Country (2016-2021)
Table 83. Latin Americaa Parkinson's Disease (PD) Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 84. Latin America Parkinson's Disease (PD) Drugs Revenue Market Share by Country (2016-2021)
Table 85. Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Country (2016-2021) & (K Pcs)
Table 86. Middle East and Africa Parkinson's Disease (PD) Drugs Sales Market Share by Country (2016-2021)
Table 87. Middle East and Africa Parkinson's Disease (PD) Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 88. Middle East and Africa Parkinson's Disease (PD) Drugs Revenue Market Share by Country (2016-2021)
Table 89. Boehringer Ingelheim Corporation Information
Table 90. Boehringer Ingelheim Description and Business Overview
Table 91. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 92. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product
Table 93. Boehringer Ingelheim Recent Development
Table 94. GlaxoSmithKline Corporation Information
Table 95. GlaxoSmithKline Description and Business Overview
Table 96. GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 97. GlaxoSmithKline Product
Table 98. GlaxoSmithKline Recent Development
Table 99. Novartis Corporation Information
Table 100. Novartis Description and Business Overview
Table 101. Novartis Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 102. Novartis Product
Table 103. Novartis Recent Development
Table 104. Teva Pharmaceutical Industries Corporation Information
Table 105. Teva Pharmaceutical Industries Description and Business Overview
Table 106. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 107. Teva Pharmaceutical Industries Product
Table 108. Teva Pharmaceutical Industries Recent Development
Table 109. AbbVie Corporation Information
Table 110. AbbVie Description and Business Overview
Table 111. AbbVie Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 112. AbbVie Product
Table 113. AbbVie Recent Development
Table 114. Abital Pharma Corporation Information
Table 115. Abital Pharma Description and Business Overview
Table 116. Abital Pharma Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 117. Abital Pharma Product
Table 118. Abital Pharma Recent Development
Table 119. Addex Therapeutics Corporation Information
Table 120. Addex Therapeutics Description and Business Overview
Table 121. Addex Therapeutics Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 122. Addex Therapeutics Product
Table 123. Addex Therapeutics Recent Development
Table 124. Biogen Corporation Information
Table 125. Biogen Description and Business Overview
Table 126. Biogen Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 127. Biogen Product
Table 128. Biogen Recent Development
Table 129. Eisai Corporation Information
Table 130. Eisai Description and Business Overview
Table 131. Eisai Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 132. Eisai Product
Table 133. Eisai Recent Development
Table 134. Eli Lilly Corporation Information
Table 135. Eli Lilly Description and Business Overview
Table 136. Eli Lilly Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 137. Eli Lilly Product
Table 138. Eli Lilly Recent Development
Table 139. F. Hoffmann-La Roche Corporation Information
Table 140. F. Hoffmann-La Roche Description and Business Overview
Table 141. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 142. F. Hoffmann-La Roche Product
Table 143. F. Hoffmann-La Roche Recent Development
Table 144. H. Lundbeck Corporation Information
Table 145. H. Lundbeck Description and Business Overview
Table 146. H. Lundbeck Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 147. H. Lundbeck Product
Table 148. H. Lundbeck Recent Development
Table 149. Impax Laboratories Corporation Information
Table 150. Impax Laboratories Description and Business Overview
Table 151. Impax Laboratories Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 152. Impax Laboratories Product
Table 153. Impax Laboratories Recent Development
Table 154. Kyowa Hakko Kirin Corporation Information
Table 155. Kyowa Hakko Kirin Description and Business Overview
Table 156. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 157. Kyowa Hakko Kirin Product
Table 158. Kyowa Hakko Kirin Recent Development
Table 159. Otsuka Pharmaceutical Corporation Information
Table 160. Otsuka Pharmaceutical Description and Business Overview
Table 161. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 162. Otsuka Pharmaceutical Product
Table 163. Otsuka Pharmaceutical Recent Development
Table 164. Pfizer Corporation Information
Table 165. Pfizer Description and Business Overview
Table 166. Pfizer Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 167. Pfizer Product
Table 168. Pfizer Recent Development
Table 169. Parkinson's Disease (PD) Drugs Market Trends
Table 170. Parkinson's Disease (PD) Drugs Market Drivers
Table 171. Parkinson's Disease (PD) Drugs Market Challenges
Table 172. Parkinson's Disease (PD) Drugs Market Restraints
Table 173. Parkinson's Disease (PD) Drugs Customers List
Table 174. Parkinson's Disease (PD) Drugs Distributors List
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Parkinson's Disease (PD) Drugs Product Picture
Figure 2. Global Parkinson's Disease (PD) Drugs Sales Market Share by Type in 2020 & 2027
Figure 3. Dopamine Agonist Product Picture
Figure 4. Monoamine Oxidase Inhibitors Product Picture
Figure 5. Acetylcholinesterase Inhibitors Product Picture
Figure 6. Glutamate Inhibitors Product Picture
Figure 7. Global Parkinson's Disease (PD) Drugs Sales Market Share by Application in 2020 & 2027
Figure 8. Hospital
Figure 9. Family
Figure 10. Parkinson's Disease (PD) Drugs Report Years Considered
Figure 11. Global Parkinson's Disease (PD) Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Parkinson's Disease (PD) Drugs Market Size 2016-2027 (US$ Million)
Figure 13. Global Parkinson's Disease (PD) Drugs Sales 2016-2027 (K Pcs)
Figure 14. Global Parkinson's Disease (PD) Drugs Market Size Market Share by Region: 2021 Versus 2027
Figure 15. Global Parkinson's Disease (PD) Drugs Sales Market Share by Region (2016-2021)
Figure 16. Global Parkinson's Disease (PD) Drugs Sales Market Share by Region in 2020
Figure 17. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Region (2016-2021)
Figure 18. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Region in 2020
Figure 19. Global Parkinson's Disease (PD) Drugs Sales Share by Manufacturer in 2020
Figure 20. The Top 10 and 5 Players Market Share by Parkinson's Disease (PD) Drugs Revenue in 2020
Figure 21. Parkinson's Disease (PD) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 22. Global Parkinson's Disease (PD) Drugs Sales Market Share by Type (2016-2021)
Figure 23. Global Parkinson's Disease (PD) Drugs Sales Market Share by Type in 2020
Figure 24. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Type (2016-2021)
Figure 25. Global Parkinson's Disease (PD) Drugs Revenue Market
  • Global and Japan Parkinsons Disease Drug Market Insights, Forecast to 2027
    Published: 18-Oct-2021        Price: US 3900 Onwards        Pages: 149
    Parkinsons Disease Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Parkinsons Disease Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For Japan market, this report focuses on the Parkinson......
  • United States Parkinson's Disease Therapeutics Market Report & Forecast 2021-2027
    Published: 12-Oct-2021        Price: US 3400 Onwards        Pages: 105
    United States Parkinson's Disease Therapeutics Market, By Type, 2016-2021, 2022-2027 ($ Millions) United States Parkinson's Disease Therapeutics Market Segment Percentages, By Type, 2020 (%) - Sinemet-CR - Trastal - Madopar - COMT Inhibitor - Other United States Parkinson's Disease Therapeutics Market, By Application, 2016-2021, 2022-2027 ($ Millions) United States Parkinson's Disease Therapeutics Market Segment Percentages, By Appl......
  • Global and China Parkinson's Disease (PD) Drugs Market Insights, Forecast to 2027
    Published: 12-Oct-2021        Price: US 3900 Onwards        Pages: 152
    Parkinson's Disease (PD) Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Parkinson's Disease (PD) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this report focuses on......
  • Global and China Rasagiline Tablet Market Insights, Forecast to 2027
    Published: 11-Aug-2021        Price: US 3900 Onwards        Pages: 144
    Rasagiline Tablet market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Rasagiline Tablet market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this report focuses on the Rasagiline Tablet mar......
  • Global and Japan Parkinson's Disease Therapeutics Market Size, Status and Forecast 2021-2027
    Published: 03-Aug-2021        Price: US 3900 Onwards        Pages: 121
    Market Analysis and Insights: Global Parkinson's Disease Therapeutics Market The global Parkinson's Disease Therapeutics market size is projected to reach US$ 3745.7 million by 2027, from US$ 2415 million in 2020, at a CAGR of 6.0% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Parkinson's Disease Therapeutics market to help players in achieving a strong ......
  • Global Parkinson's Disease Therapeutics Market Size, Status and Forecast 2021-2027
    Published: 19-Jul-2021        Price: US 3900 Onwards        Pages: 117
    Market Analysis and Insights: Global Parkinson's Disease Therapeutics Market The global Parkinson's Disease Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Parkinson's Disease Therapeutics market to help players in achieving a strong market ......
  • Rasagiline Tablet Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product Type
    Published: 11-Jul-2021        Price: US 3200 Onwards        Pages: 77
    This report describes the global market size of Rasagiline Tablet from 2016 to 2020 and its CAGR from 2016 to 2020, and also forecasts its market size to the end of 2026 and its CAGR from 2021 to 2026. For geography segment, regional supply, demand, major players, price is presented from 2016 to 2026. This report cover following regions: North America South America Asia & Pacific Europe MEA The key countries for each regions are also includ......
  • Global Parkinsons disease Drug Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 04-Jun-2021        Price: US 3480 Onwards        Pages: 106
    The Parkinsons disease Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our latest......
  • Global Parkinsons disease Drug Sales Market Report 2021
    Published: 03-Jun-2021        Price: US 4000 Onwards        Pages: 149
    The global Parkinsons disease Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Parkinsons disease Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Carbidopa/Levodopa - Dopamine......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs